Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Concord Medical Officially Opens New Specialty Cancer Hospital in Guangzhou 2021-06-11 18:11
Yingli Pharma Announces a presentation on the Phase 2 clinical trial of linperlisib, a PI3Kδ selective inhibitor, in relapsed or refractory follicular lymphoma at the European Hematology Association 2021 Congress 2021-06-11 13:05
Happiness Biotech Entered Into Electric Vehicle Distribution Agreement With Geely's Subsidiary 2021-06-10 21:00
OliPass Expands Scientific Advisory Board by Inviting Experts in Pain To Bolster Phase 2 Clinical Trial Design and Management 2021-06-10 21:00
VinBrain and FIT Jointly Release a White Paper on Utilizing Artificial Intelligence in Tuberculosis Screening 2021-06-10 17:11
Verona Pharma and Nuance Pharma Announce $219 Million Strategic Collaboration to Develop and Commercialize Ensifentrine in Greater China 2021-06-10 14:00
Peijia Medical Partners with inQB8 for US Incubator and Transcatheter Tricuspid Replacement (TTVR) Product 2021-06-10 10:26
Travecta Therapeutics Appoints Charles S. Ryan as President and Chief Executive Officer 2021-06-09 21:00
China Pharma to Launch Highly Purified NMN+PQQ Product 2021-06-09 20:00
Study of Paxalisib in Primary CNS Lymphoma at Dana-Farber Cancer Institute Enrols First Patient 2021-06-07 20:00
Yingli Pharma Announces presentations on the Phase 1 trials of linperlisib, a PI3Kδ selective inhibitor, and YL-13027, an oral TGFβR1 inhibitor, at the American Society for Clinical Oncology 2021 Annual Meeting 2021-06-04 14:29
AI-based Analysis of Cancer Tissue Predicts Response to Immunotherapy--Findings to Be Presented at ASCO 2021 2021-06-04 02:14
China NMPA Approves MicuRx's Contezolid for Treatment of Drug-Resistant Bacterial Infection 2021-06-03 22:15
Registration Open for the 4th China Medical Devices Design & Entrepreneurship Competition 2021 2021-06-03 09:58
Cell Care Joins the Generate Life Sciences Family to Create a Global Platform 2021-06-03 06:00
GenScript Biotech and Ligand Pharmaceuticals Enter into Global OmniAb® Licensing Agreement 2021-06-02 21:00
Shanghai Asclepius Meditec and International Department of Central Committee of CPC Collaborate to Provide Emergency Support to Fight COVID-19 in Nepal 2021-06-02 20:00
PharmAbcine to Present at the BIO Digital International Convention 2021 2021-06-02 20:00
Samsung Biologics and KAHR Medical Announce Development and Manufacturing Agreement for Cancer Immunotherapy Drug Candidate 2021-06-02 19:00
ImmVira will present the U.S. Clinical Phase I Study Results of MVR-T3011 via Intratumoral Administration at ASCO 2021 2021-06-02 16:14
1 149 150 151 152 153 410